ProShare Advisors’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.3K | Sell |
25,970
-1,797
| -6% | -$6.11K | ﹤0.01% | 1898 |
|
|
2025
Q1 | $111K | Sell |
27,767
-8,474
| -23% | -$34K | ﹤0.01% | 1814 |
|
|
2024
Q4 | $235K | Buy |
36,241
+11,213
| +45% | +$72.8K | ﹤0.01% | 1803 |
|
|
2024
Q3 | $139K | Buy |
25,028
+6,881
| +38% | +$38.1K | ﹤0.01% | 1822 |
|
|
2024
Q2 | $101K | Sell |
18,147
-5,794
| -24% | -$32.3K | ﹤0.01% | 1663 |
|
|
2024
Q1 | $161K | Buy |
23,941
+1,687
| +8% | +$11.3K | ﹤0.01% | 1726 |
|
|
2023
Q4 | $203K | Buy |
22,254
+4,292
| +24% | +$39.1K | ﹤0.01% | 1633 |
|
|
2023
Q3 | $99.2K | Buy |
17,962
+109
| +0.6% | +$602 | ﹤0.01% | 1633 |
|
|
2023
Q2 | $152K | Buy |
17,853
+4,414
| +33% | +$37.7K | ﹤0.01% | 1605 |
|
|
2023
Q1 | $124K | Sell |
13,439
-1,254
| -9% | -$11.5K | ﹤0.01% | 1555 |
|
|
2022
Q4 | $150K | Buy |
14,693
+2,106
| +17% | +$21.5K | ﹤0.01% | 1561 |
|
|
2022
Q3 | $185K | Sell |
12,587
-240
| -2% | -$3.53K | ﹤0.01% | 1426 |
|
|
2022
Q2 | $138K | Sell |
12,827
-5,479
| -30% | -$58.9K | ﹤0.01% | 1551 |
|
|
2022
Q1 | $197K | Buy |
+18,306
| New | +$197K | ﹤0.01% | 1894 |
|